Shuttle Pharmaceuticals Holdings (SHPH) Other financing activities (2023 - 2025)
Shuttle Pharmaceuticals Holdings' (SHPH) quarterly Other financing activities came in at $349.0 in Q4 2025, up 100.35% year-on-year from $174.2 in Q4 2024, and up 100.6% quarter-over-quarter from -$58612.0 in Q3 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Other financing activities (2023 - 2025) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Other financing activities history runs 3 years deep, the most recent figure standing at $349.0 for Q4 2025.
- On a quarterly basis, Other financing activities rose 100.35% year-over-year to $349.0 in Q4 2025; TTM through Dec 2025 was $20151.0, a 133.08% increase from a year earlier, with the FY2025 full-year figure at $20151.0, up 2664.2% from the prior year.
- Other financing activities improved to $349.0 in Q4 2025 per SHPH's latest filing, from -$58612.0 in the prior quarter.
- Across five years, Other financing activities topped out at $345000.0 in Q1 2023 and bottomed at -$100922.0 in Q4 2024.
- The 3-year median for Other financing activities is $28413.0 (2025), against an average of $43461.3.
- Across the five-year window, Other financing activities plunged 88.41% in 2024 and jumped 100.35% in 2025, its largest moves.
- Year by year, Other financing activities stood at $345000.0 in 2023, then tumbled by 129.25% to -$100922.0 in 2024, then jumped by 100.35% to $349.0 in 2025.
- Per Business Quant, the three latest SHPH Other financing activities figures stand at $349.0 (Q4 2025), -$58612.0 (Q3 2025), and $28413.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Shuttle Pharmaceuticals Holdings | 120,186.04 | 120,186.04 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 349.00 |
| Dec 31, 2025 | 349.00 |
| Sep 30, 2025 | -58,612.00 |
| Sep 30, 2025 | -58,612.00 |
| Jun 30, 2025 | 28,413.00 |
| Jun 30, 2025 | 28,413.00 |
| Mar 31, 2025 | 50,001.00 |
| Mar 31, 2025 | 50,001.00 |
| Dec 31, 2024 | -100,922.00 |
| Dec 31, 2024 | -100,922.00 |
| Mar 31, 2024 | 40,000.00 |
| Mar 31, 2024 | 40,000.00 |
| Mar 31, 2023 | 345,000.00 |
| Mar 31, 2023 | 345,000.00 |